Seeking Alpha

While multiple-sclerosis patients have waited years for pills to be developed to treat the...

While multiple-sclerosis patients have waited years for pills to be developed to treat the debilitating disease, doctors are warning them to be wary. That's because drugs such as Novartis' (NVS) Gilenya and Sanofi's (SNY) Aubagio can have significant side-effects. All of which is positive for Teva (TEVA), whose Copaxone is injected rather than taken orally.
Comments (4)
  • doc47
    , contributor
    Comments (1052) | Send Message
     
    And yet the ongoing threats of full scale war in the Middle East seem to trump any good news there and the stock goes nowhere.
    20 Nov 2012, 10:01 AM Reply Like
  • FrankArabia
    , contributor
    Comments (503) | Send Message
     
    you should be happy the stock is down.....buy more....
    20 Nov 2012, 10:02 AM Reply Like
  • baseballman24
    , contributor
    Comments (301) | Send Message
     
    Teva is the most under valued stock in the world, nw they will get a currency boost and there plants have very little exposure to gaza.
    20 Nov 2012, 11:01 AM Reply Like
  • FrankArabia
    , contributor
    Comments (503) | Send Message
     
    it is by no means the most undervalued.....but it is cheap....long TEVA
    20 Nov 2012, 12:31 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|